Results
|
81.
|
|
|
82.
|
|
|
83.
|
|
|
84.
|
|
|
85.
|
|
|
86.
|
|
|
87.
|
|
|
88.
|
|
|
89.
|
|
|
90.
|
|
|
91.
|
|
|
92.
|
|
|
93.
|
|
|
94.
|
|
|
95.
|
|
|
96.
|
|
|
97.
|
Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open-label, 48-week extension study. [electronic resource] by
- Panés, Julián
- D'Haens, Geert R
- Higgins, Peter D R
- Mele, Linda
- Moscariello, Michele
- Chan, Gary
- Wang, Wenjin
- Niezychowski, Wojciech
- Su, Chinyu
- Maller, Eric
Producer: 20200106
In:
Alimentary pharmacology & therapeutics vol. 49
Availability: No items available.
|
|
98.
|
|
|
99.
|
|
|
100.
|
|